Zum Hauptinhalt springen
Hochschulbibliothek der Hochschule Düsseldorf

Suchergebnisse

Katalog

Mehr
126 Treffer

Suchmaske

Suchtipp für den Bereich Mehr: Wörter werden automatisch mit UND verknüpft. Eine ODER-Verknüpfung erreicht man mit dem Zeichen "|", eine NICHT-Verknüpfung mit einem "-" (Minus) vor einem Wort. Anführungszeichen ermöglichen eine Phrasensuche.
Beispiele: (burg | schloss) -mittelalter, "berufliche bildung"

Das folgende Suchfeld wird hier nicht unterstützt: "Signatur".

Suchergebnisse einschränken oder erweitern

Aktive Suchfilter

Erscheinungszeitraum

Mehr Treffer

Weniger Treffer

Art der Quelle

Thema

Verlag

Publikation

Sprache

Geographischer Bezug

Inhaltsanbieter

126 Treffer

Sortierung: 
  1. Detailansicht für Treffer 1 öffnen
    Data from Osaka University Graduate School of Medicine Advance Knowledge in Ovarian Cancer (SLFN11 is a BRCA independent biomarker for the response to platinum-based chemotherapy in high-grade serous ovarian cancer and clear cell ovarian...).
    In: Women's Health Weekly, 2023-10-06, S. 173-173
    serialPeriodical
    Wie komme ich dran?
  2. Detailansicht für Treffer 2 öffnen
    "Pan-Cancer Platinum Response Predictor" in Patent Application Approval Process (USPTO 20240177821).
    In: Women's Health Weekly, 2024-06-21, S. 1776-1776
    serialPeriodical
    Wie komme ich dran?
  3. Detailansicht für Treffer 3 öffnen
    Researchers Submit Patent Application, "Systems And Methods For Predicting Response Of Triple-Negative Breast Cancer To Neoadjuvant Chemotherapy", for Approval (USPTO 20240161276).
    In: Women's Health Weekly, 2024-06-06, S. 2051-2051
    serialPeriodical
    Wie komme ich dran?
  4. Detailansicht für Treffer 4 öffnen
    Researcher's Work from Pusan National University Hospital Focuses on Breast Cancer [Impact of Neoadjuvant Chemotherapy (NAC) on Biomarker Expression in Breast Cancer].
    In: Women's Health Weekly, 2024-05-24, S. 976-976
    serialPeriodical
    Wie komme ich dran?
  5. Detailansicht für Treffer 5 öffnen
    A Multicenter, Single-Arm Pilot Study of Immune Checkpoint Inhibitors in Patients With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Who Had Long-Term (Two Years or Longer) Response to First-Line Immunotherapy.
    In: Women's Health Weekly, 2024-05-14, S. 61-61
    serialPeriodical
    Wie komme ich dran?
  6. Detailansicht für Treffer 6 öffnen
    ACE inhibitor not protective against heart damage from chemotherapy.
    In: Hematology Week, 2024-04-22, S. 128-128
    serialPeriodical
    Wie komme ich dran?
  7. Detailansicht für Treffer 7 öffnen
    A Prospective, Single Center Clinical Study on the Clinical Significance of Personalized ctDNA-MRD in Predicting the Efficacy and Monitoring the Risk of Recurrence of Cervical Cancer.
    In: Women's Health Weekly, 2024-03-15, S. 66-66
    serialPeriodical
    Wie komme ich dran?
  8. Detailansicht für Treffer 8 öffnen
    NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS).
    In: Women's Health Weekly, 2024-02-23, S. 432-432
    serialPeriodical
    Wie komme ich dran?
  9. Detailansicht für Treffer 9 öffnen
    Reports Outline Breast Cancer Research from State University of New York - Stony Brook University (Biomarkers and Strain Echocardiography for the Detection of Subclinical Cardiotoxicity in Breast Cancer Patients Receiving Anthracyclines).
    In: Women's Health Weekly, 2024-01-02, S. 793-793
    serialPeriodical
    Wie komme ich dran?
  10. Detailansicht für Treffer 10 öffnen
    Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer.
    In: Women's Health Weekly, 2023-11-14, S. 494-494
    serialPeriodical
    Wie komme ich dran?
  11. Detailansicht für Treffer 11 öffnen
    Efficacy and Safety of Cadonilimab (AK104) Plus Chemotherapy in the Treatment of Recurrent or Advanced Endometrial Cancer: a Multicenter, Prospective Phase II Trial.
    In: Cancer Vaccine Week, 2023-10-16, S. 143-143
    serialPeriodical
    Wie komme ich dran?
  12. Detailansicht für Treffer 12 öffnen
    Study Findings on Breast Cancer Described by a Researcher at University of Rome (Quantification of Extracellular Volume in CT in Neoadjuvant Chemotherapy in Breast Cancer: New Frontiers in Assessing the Cardiotoxicity of Anthracyclines and ...).
    In: Women's Health Weekly, 2023-02-07, S. 1848-1848
    serialPeriodical
    Wie komme ich dran?
  13. Detailansicht für Treffer 13 öffnen
    Clinical Study to Evaluate the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity in Breast Cancer Patients.
    In: Women's Health Weekly, 2024-06-11, S. 138-138
    serialPeriodical
    Wie komme ich dran?
  14. Detailansicht für Treffer 14 öffnen
    Serum Proteome Profiling Identifies N-Cadherin and C-Met as Early Marker Candidates of Therapeutic Response to Neoadjuvant Chemotherapy in Breast Cancer.
    In: Women's Health Weekly, 2024-06-11, S. 1265-1265
    serialPeriodical
    Wie komme ich dran?
  15. Detailansicht für Treffer 15 öffnen
    New Findings from George Mason University in the Area of Ovarian Cancer Published (Evaluating Ovarian Cancer Chemotherapy Response Using Gene Expression Data and Machine Learning).
    In: Women's Health Weekly, 2024-06-11, S. 627-627
    serialPeriodical
    Wie komme ich dran?
  16. Detailansicht für Treffer 16 öffnen
    Findings from Catholic University of Korea College of Medicine Advance Knowledge in Breast Cancer (Contrast-enhanced ultrasound features as potential biomarker for prediction of breast cancer recurrence).
    In: Women's Health Weekly, 2024-06-11, S. 283-283
    serialPeriodical
    Wie komme ich dran?
  17. Detailansicht für Treffer 17 öffnen
    Study Results from Sun Yat-sen University Broaden Understanding of Liposomes (Abstract PO1-01-02: Final analysis of neoadjuvant chemotherapy with pegylated liposomal doxorubicin/cyclophosphamide followed by taxanes with full-course...).
    In: Women's Health Weekly, 2024-05-24, S. 1251-1251
    serialPeriodical
    Wie komme ich dran?
  18. Detailansicht für Treffer 18 öffnen
    Study Data from Tianjin Medical University Cancer Institute and Hospital Provide New Insights into Breast Cancer (Abstract PO4-18-04: An exploratory study of Trastuzumab Deruxtecan neoadjuvant therapy in HER2-positive or HER2-low early or...).
    In: Women's Health Weekly, 2024-05-24, S. 1179-1179
    serialPeriodical
    Wie komme ich dran?
  19. Detailansicht für Treffer 19 öffnen
    Study Data from Chang Gung University College of Medicine Provide New Insights into Breast Cancer (PFDN4 as a Prognostic Marker Was Associated with Chemotherapy Resistance through CREBP1/AURKA Pathway in Triple-Negative Breast Cancer).
    In: Women's Health Weekly, 2024-05-02, S. 1159-1159
    serialPeriodical
    Wie komme ich dran?
  20. Detailansicht für Treffer 20 öffnen
    New Breast Cancer Research Reported from David Geffen School of Medicine University of California Los Angeles (UCLA) (EMP2 Serves as a Functional Biomarker for Chemotherapy-Resistant Triple-Negative Breast Cancer).
    In: Women's Health Weekly, 2024-05-02, S. 498-498
    serialPeriodical
    Wie komme ich dran?

Weitere Bibliothekskataloge

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -